What's new

[Cyprus Times] The two risks for those who recovered from coronavirus. Worrying study results

sciencesars-1.jpg

This study showed that the incidence of cardiometabolic problems increases in the first months after COVID-19

A new study, recently published in the international journal PLOS Medicine, showed that the incidence of cardiovascular disease, mainly pulmonary embolism, atrial arrhythmias and venous thrombosis, increased for the first period after coronavirus, while the incidence of diabetes mellitus also remained elevated for at least 12 weeks afterwards.

Professors Stavroula (Lina) Paschou (Assistant Professor of Endocrinology) Theodora Psaltopoulou (Professor of Therapeutics-Epidemiology-Preventive Medicine) and Thanos Dimopoulos (Professor of Therapeutics-Immunology-Oncology and Dean of the School of Medicine of EKPA) summarize the main points of this study.

Survey of more than 400,000 patients

The researchers analysed electronic records of 428,650 COVID-19 patients from the UK without diabetes mellitus or cardiovascular disease, matched to 428,650 control patients by age and sex and followed up until January 2022. The median follow-up duration was 12 months, and the follow-up time was divided into 4 weeks from the date of infection, 5 to 12 weeks after, and 13 to 52 weeks after. There was a slight female predominance in the study population, with a median age of 35 years.

We found that diabetes mellitus incidence increased in the first 4 weeks after COVID-19 (adjusted rate ratio [RR] 1.81, 95% confidence interval [CI] 1.51-2.19, P < 0.001) and remained elevated from 5 to 12 weeks (RR 1.27, 95% CI 1.11-1.46, P < 0.001) but not from 13 to 52 weeks (RR 1.07, 95% CI 0.99-1.16, P = 0.07).

Similarly, the initial period after COVID-19 was associated with an increased incidence for cardiovascular disease, mainly pulmonary embolism, atrial arrhythmias, and venous thrombosis (RR 5.82, 95% CI 4.82-7.03, P < 0.001) with the incidence decreasing at 5 to 12 weeks post-treatment (RR 1.49, 95% CI 1.2-1.73, P < 0.001). The incidence of cardiovascular disease decreased markedly from 13 to 52 weeks after (RR 0.80, 95% CI 0.73-0.88, P < 0.001).

Conclusions



In conclusion, this study demonstrated that the incidence of cardiometabolic problems increased in the first months after COVID-19. Advice to recovering patients should therefore include relevant measures, including diet, weight management and increased levels of physical activity.

Source: in.gr


Contents of this article including associated images are belongs to Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top